Psychiatry News

PHILADELPHIA — Longer sleep duration may be linked to neurodegeneration as a likely risk factor for future cognitive decline and dementia, with depression also influencing sleep and cognitive deficit, according to a poster presentation.

In a new study published in the Journal of Drugs in Dermatology, researchers discussed how and why dermatologists have a significant role to play in the diagnosing and addressing of body dysmorphic disorder.

PHILADELPHIA — Among men who played American football, researchers found that exposure to the sport at a younger age was strongly associated with worse cognitive performance and resilience, particularly in those who lived to at least 60 years.

PHILADELPHIA — In cognitively healthy but sleep-poor adults in midlife, treatment with 20 mg suvorexin led to acute decreases in Alzheimer’s-related biomarkers compared with 10 mg of the drug and placebo, according to a presenter.

PHILADELPHIA — Tackling 14 risk factors for dementia beginning in childhood could prevent or delay nearly half of cases, according to a report from the Lancet Commission presented at the Alzheimer's Association International Conference.

Black individuals experienced nonfatal firearm assaults at a rate 20 times higher than their white counterparts in 2019 and 2020, according to new study results published in the Annals of Internal Medicine.

Risk for psychiatric disorder or suicide attempt is particularly high in the first year following hospitalization for heart disease, and patient support is important to lower such risk, researchers reported.

PHILADELPHIA — Script generation task performance may be a cost-effective, reliable tool to assess early cognitive impairment in older adults, according to a poster presentation.

PHILADELPHIA — Individuals who consumed about two weekly servings of processed red meat had a 14% higher risk for dementia, as well as accelerated cognitive aging, vs. those who ate less than three servings a month, according to research.

PHILADELPHIA — Treatment with liraglutide appeared to reduce cognitive decline and slow volume loss in several areas of the brain after 1 year among individuals with mild to moderate Alzheimer’s dementia, according to new research.